AbbVie (ABBV) Operating Income (2016 - 2025)
Historic Operating Income for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $1.9 billion.
- AbbVie's Operating Income fell 5030.02% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 billion, marking a year-over-year decrease of 3458.98%. This contributed to the annual value of $9.1 billion for FY2024, which is 2837.66% down from last year.
- AbbVie's Operating Income amounted to $1.9 billion in Q3 2025, which was down 5030.02% from $4.9 billion recorded in Q2 2025.
- AbbVie's 5-year Operating Income high stood at $5.5 billion for Q4 2022, and its period low was -$1.5 billion during Q4 2024.
- Over the past 5 years, AbbVie's median Operating Income value was $4.0 billion (recorded in 2024), while the average stood at $3.6 billion.
- As far as peak fluctuations go, AbbVie's Operating Income skyrocketed by 49055.85% in 2021, and later crashed by 14663.54% in 2024.
- AbbVie's Operating Income (Quarter) stood at $5.1 billion in 2021, then increased by 8.44% to $5.5 billion in 2022, then plummeted by 41.93% to $3.2 billion in 2023, then plummeted by 146.64% to -$1.5 billion in 2024, then skyrocketed by 227.79% to $1.9 billion in 2025.
- Its Operating Income stands at $1.9 billion for Q3 2025, versus $4.9 billion for Q2 2025 and $3.7 billion for Q1 2025.